日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/05/11 | 6,160 | 6,210 | 6,150 | 6,160 | -60 | -1% | 171,200 |
2023/05/10 | 6,280 | 6,290 | 6,200 | 6,220 | -70 | -1.1% | 169,700 |
2023/05/09 | 6,240 | 6,310 | 6,230 | 6,290 | +60 | +1% | 184,900 |
2023/05/08 | 6,290 | 6,290 | 6,190 | 6,230 | ±0 | ±0% | 204,500 |
2023/05/02 | 6,300 | 6,320 | 6,190 | 6,230 | -40 | -0.6% | 148,500 |
2023/05/01 | 6,260 | 6,290 | 6,220 | 6,270 | +70 | +1.1% | 199,800 |
2023/04/28 | 6,190 | 6,260 | 6,180 | 6,200 | +70 | +1.1% | 205,800 |
2023/04/27 | 6,090 | 6,140 | 6,060 | 6,130 | -10 | -0.2% | 157,800 |
2023/04/26 | 6,200 | 6,270 | 6,120 | 6,140 | -100 | -1.6% | 280,700 |
2023/04/25 | 6,180 | 6,290 | 6,140 | 6,240 | +60 | +1% | 271,300 |
2023/04/24 | 6,220 | 6,240 | 6,160 | 6,180 | -10 | -0.2% | 245,500 |
2023/04/21 | 6,070 | 6,250 | 6,040 | 6,190 | +120 | +2% | 342,100 |
2023/04/20 | 6,230 | 6,230 | 6,010 | 6,070 | +20 | +0.3% | 353,800 |
2023/04/19 | 6,020 | 6,110 | 5,980 | 6,050 | -70 | -1.1% | 273,000 |
2023/04/18 | 6,160 | 6,230 | 6,090 | 6,120 | +40 | +0.7% | 262,400 |
2023/04/17 | 6,150 | 6,230 | 6,060 | 6,080 | -130 | -2.1% | 342,300 |
2023/04/14 | 6,220 | 6,270 | 6,160 | 6,210 | +290 | +4.9% | 728,100 |
2023/04/13 | 5,830 | 5,930 | 5,810 | 5,920 | +60 | +1% | 345,300 |
2023/04/12 | 5,830 | 5,880 | 5,820 | 5,860 | +110 | +1.9% | 413,700 |
2023/04/11 | 5,750 | 5,800 | 5,710 | 5,750 | ±0 | ±0% | 235,000 |
2023/04/10 | 5,730 | 5,750 | 5,700 | 5,750 | +50 | +0.9% | 185,800 |
2023/04/07 | 5,790 | 5,790 | 5,690 | 5,700 | -50 | -0.9% | 160,600 |
2023/04/06 | 5,690 | 5,770 | 5,650 | 5,750 | +40 | +0.7% | 301,200 |
2023/04/05 | 5,900 | 5,900 | 5,710 | 5,710 | -190 | -3.2% | 242,400 |
2023/04/04 | 5,920 | 5,920 | 5,820 | 5,900 | +20 | +0.3% | 260,100 |
2023/04/03 | 5,850 | 5,940 | 5,840 | 5,880 | +50 | +0.9% | 323,200 |
2023/03/31 | 5,820 | 5,850 | 5,750 | 5,830 | ±0 | ±0% | 347,100 |
2023/03/30 | 5,880 | 5,900 | 5,780 | 5,830 | -110 | -1.9% | 226,800 |
2023/03/29 | 5,940 | 5,940 | 5,850 | 5,940 | +10 | +0.2% | 309,000 |
2023/03/28 | 5,940 | 5,960 | 5,870 | 5,930 | +30 | +0.5% | 263,400 |
2023/03/27 | 5,920 | 5,980 | 5,880 | 5,900 | -10 | -0.2% | 242,600 |
2023/03/24 | 5,890 | 5,930 | 5,860 | 5,910 | +30 | +0.5% | 240,000 |
2023/03/23 | 5,900 | 5,920 | 5,850 | 5,880 | -70 | -1.2% | 319,500 |
2023/03/22 | 5,950 | 6,020 | 5,900 | 5,950 | +100 | +1.7% | 425,500 |
2023/03/20 | 5,860 | 6,000 | 5,780 | 5,850 | -140 | -2.3% | 680,800 |
2023/03/17 | 5,600 | 6,010 | 5,590 | 5,990 | +610 | +11.3% | 1,473,300 |
2023/03/16 | 5,360 | 5,420 | 5,260 | 5,380 | -50 | -0.9% | 602,400 |
2023/03/15 | 5,510 | 5,570 | 5,430 | 5,430 | -30 | -0.5% | 391,900 |
2023/03/14 | 5,540 | 5,540 | 5,410 | 5,460 | -110 | -2% | 433,100 |
2023/03/13 | 5,660 | 5,700 | 5,530 | 5,570 | -120 | -2.1% | 519,700 |
2023/03/10 | 5,740 | 5,790 | 5,680 | 5,690 | -150 | -2.6% | 636,400 |
2023/03/09 | 5,910 | 5,920 | 5,830 | 5,840 | -30 | -0.5% | 435,600 |
2023/03/08 | 5,860 | 5,910 | 5,790 | 5,870 | ±0 | ±0% | 583,600 |
2023/03/07 | 5,880 | 5,940 | 5,840 | 5,870 | -70 | -1.2% | 457,100 |
2023/03/06 | 5,990 | 6,000 | 5,890 | 5,940 | -20 | -0.3% | 318,800 |
2023/03/03 | 5,890 | 6,000 | 5,870 | 5,960 | +70 | +1.2% | 428,700 |
2023/03/02 | 5,810 | 5,960 | 5,810 | 5,890 | -10 | -0.2% | 395,300 |
2023/03/01 | 6,010 | 6,050 | 5,900 | 5,900 | -200 | -3.3% | 413,400 |
2023/02/28 | 6,110 | 6,180 | 6,040 | 6,100 | +20 | +0.3% | 493,800 |
2023/02/27 | 6,060 | 6,080 | 6,010 | 6,080 | -30 | -0.5% | 415,100 |
251~
300
件表示中 / 3457件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 369,300円 | +1.2% | -6.3% | 3.36% | 10.16倍 | 1.13倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ツムラ | 395,700円 | +22.6% | +68.1% | 3.44% | 10.55倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サワイGHD | 610,500円 | +14.2% | +48.9% | 2.60% | 8.91倍 | 1.26倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 191,500円 | +56.7% | +357.2% | 0.00% | 17.73倍 | 6.15倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
科研薬 | 344,000円 | +4.2% | -21.6% | 4.36% | 23.27倍 | 0.91倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム